

HY-174908 · 50 mg
MedChemExpress · Cat: HY-174908
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/sjl2-1.htmlDescription
SJL2-1 is a PRMT5 inhibitor, with an IC50 of 1.56 ?M. SJL2-1 suppresses proliferation, migration, and invasion in prostate cancer cells. SJL2-1 promotes apoptosis and blocks the cell cycle at the G0/G1 phase. SJL2-1 can target the binding of PRMT5 in cells and inhibit the methylation and expression of the androgen receptor. SJL2-1 can be used for the study of early androgen-sensitive prostate cancer and advanced castration-resistant prostate cancer CRPC .

